Stock QSI QUANTUM-SI INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Company Quantum-Si incorporated

Equities

QSI

US74765K1051

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
1.62 USD -2.41% Intraday chart for Quantum-Si incorporated -10.00% -19.40%
May. 15 Transcript : Quantum-Si incorporated - Shareholder/Analyst Call
May. 09 Transcript : Quantum-Si incorporated, Q1 2024 Earnings Call, May 09, 2024

Business Summary

Quantum-SI Incorporated is a life sciences company. The Company has designed and developed a hardware, consumable and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins. Its launched product consists of Platinum, the Platinum Analysis Software and consumables. Its flagship protein sequencing instrument, Platinum, is designed to make the power of single-molecule detection and NGPS accessible. Platinum is designed to provide a streamlined workflow compared to legacy MS workflows. Platinum uses its proprietary semiconductor chip that leverages time-domain sequencing with an initial focus on NGPS for an unbiased view of the proteome.

Number of employees: 159

Sales per Business

USD in Million2022Weight2023Weight Delta
Universal Single-molecule Detection Platform
100.0 %
0 nan % 1 100.0 % -

Sales per region

USD in Million2022Weight2023Weight Delta
United States
100.0 %
0 nan % 1 100.0 % -

Managers

Managers TitleAgeSince
Jeffrey Hawkins CEO
 Chief Executive Officer 46 22-10-09
Jonathan Rothberg FOU
 Founder 60 13-06-23
Jeffry Keyes DFI
 Director of Finance/CFO 51 23-05-14
Todd Rearick CTO
 Chief Tech/Sci/R&D Officer - 18-12-31
Johan Denecke COO
 Chief Operating Officer - 23-06-19
Alex Hutcheson SAM
 Sales & Marketing - 23-04-23
Grace Johnston PRN
 Corporate Officer/Principal 41 22-12-19
Christian LaPointe LAW
 General Counsel 53 20-10-31

Members of the board

Members of the board TitleAgeSince
Jonathan Rothberg FOU
 Founder 60 13-06-23
Ruth Fattori BRD
 Director/Board Member 71 21-06-09
Jeffrey Hawkins CEO
 Chief Executive Officer 46 22-10-09
Kevin Rakin BRD
 Director/Board Member 63 20-06-09
Brigid Makes BRD
 Director/Board Member 68 21-06-09
Scott Mendel BRD
 Director/Board Member 57 23-05-14
John Kenny BRD
 Director/Board Member 54 23-05-18
Amir Jafri BRD
 Director/Board Member 57 23-09-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,937,500 0 0 69.53 %
Stock B 1 121,878,989 98,605,248 ( 80.90 %) 0

Shareholders

NameEquities%Valuation
Jonathan Rothberg
14.14 %
17,232,203 14.14 % 28 M $
ARK Investment Management LLC
10.48 %
12,768,876 10.48 % 21 M $
Nikko Asset Management Americas, Inc.
6.611 %
8,054,503 6.611 % 13 M $
BlackRock Advisors LLC
5.701 %
6,945,419 5.701 % 11 M $
Vanguard Fiduciary Trust Co.
4.351 %
5,300,685 4.351 % 9 M $
Kevin Rakin
2.388 %
2,909,924 2.388 % 5 M $
STATE STREET CORPORATION
1.773 %
2,159,809 1.773 % 3 M $
Geode Capital Management LLC
1.752 %
2,134,029 1.752 % 3 M $
Jeffrey Hawkins
0.8034 %
978,757 0.8034 % 2 M $
Michael McKenna
0.7133 %
869,021 0.7133 % 1 M $
NameEquities%Valuation
Deerfield Management Co. LP (Private Equity)
-
333,333 - 78 333 $
Citadel Securities GP LLC
-
113,647 - 26 707 $
Westchester Capital Management, Inc.
-
65,618 - 15 420 $
G1 Execution Services LLC
-
37,288 - 8 763 $
HRT Financial LLC
-
28,447 - 6 685 $
Jane Street Group LLC
-
16,880 - 3 967 $
Jackson National Asset Management LLC
-
13,237 - 3 111 $
Wolverine Asset Management LLC
-
10,675 - 2 509 $
NameEquities%Valuation
Jonathan Rothberg
100.00 %
19,937,500 100.00 % 32 M $

Company contact information

Quantum-Si, Inc.

29 Business Park Drive

06405, Branford

+

http://www.quantum-si.com
address Quantum-Si incorporated(QSI)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Ratings for Quantum-Si incorporated

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
1.66 USD
Average target price
2.75 USD
Spread / Average Target
+65.66%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
QUANTUM-SI INCORPORATED Stock Quantum-Si incorporated
-19.40% 235M
MODERNA, INC. Stock Moderna, Inc.
+67.53% 62.86B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.77% 41.38B
LONZA GROUP AG Stock Lonza Group AG
+45.66% 40.38B
CELLTRION, INC. Stock Celltrion, Inc.
-10.72% 27.64B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+13.30% 26.46B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-22.79% 18.9B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+4.70% 12.67B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.10% 12.27B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+27.41% 12.07B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. QSI Stock
  4. Company Quantum-Si incorporated